Established in Shanghai in 2010, 3D Medicines (3DMed) is one of the first companies to provide oncology precision medical testing services in China. Over the years, the Company has grown into a successful Group consisting of 3DMed Diagnostics (Full company name: Etis Biotechnology (Shanghai) Co., Ltd.) .With the former already well-established as a market leader in automated and smart precision diagnostics in China.
Guided by its “Patients First” motto, the Company stepped up and joined the fight against the pandemic immediately after the outbreak of the novel coronavirus in 2020. Due to its significant contributions, the Company, based in Minhang district was recognized as a “key organization in the fight against COVID19 pandemic (Shanghai)”. At the same time, the Company has assisted in the global fight against the pandemic by developing related products and solutions such as novel coronavirus nucleic acid test kit, automated nucleic acid extraction kit, and mobile testing shelters. Its products and services are available in more than 60 countries and regions including Europe, U.S., Brazil, Australia, Middle East, Southeast Asia, and Africa.